UP
Upstream Bio, Inc. (UPB) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$9.33
+0.43%
Mkt Cap $506.11M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 26, 2026 | $584.00K | $668.00K | +14.38% | -$0.73 | -$0.79 | -8.22% | — | — |
| Q4 2025 Nov 5, 2025 | $521.57K | $683.00K | +30.95% | -$0.78 | -$0.63 | +19.23% | — | — |
| Q3 2025 Aug 6, 2025 | $317.00K | $937.00K | +195.58% | -$0.61 | -$0.74 | -21.31% | — | — |
| Q2 2025 May 6, 2025 | $317.00K | $566.00K | +78.55% | -$0.49 | -$0.51 | -4.08% | — | — |
| Q1 2025 Mar 13, 2025 | $326.25K | $613.00K | +87.89% | -$0.56 | -$1.59 | -183.93% | — | — |
| Q4 2024 Nov 7, 2024 | $397.25K | $607.00K | +52.80% | -$0.54 | -$6.96 | -1200.30% | — | — |
| Q4 2023 Dec 31, 2023 | — | $2.38M | — | — | -$0.14 | — | — | — |
| Q3 2023 Sep 30, 2023 | — | $621.00K | — | — | -$0.09 | — | — | — |